Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT06369285 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Puma Biotechnology, Inc. |
| Last Updated on CT.gov | December 10, 2025 (Dec 10, 2025) |
As of March 2, 2026: Clinical trial NCT06369285 is currently recruiting participants. This clinical trial study for breast cancer is actively seeking new participants at 33 locations across the United States. The study is sponsored by Puma Biotechnology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06369285 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06369285 was last updated Dec 10, 2025 (December 10, 2025). HelloStudys verifies this status automatically.